Research ArticleChemotherapy, Antibiotics, and Gene Therapy
FF-10502, an antimetabolite with novel activity on dormant cells, is superior to gemcitabine for targeting pancreatic cancer cells
shinji mima, Chihaya Kakinuma, Tamami Higuchi, Kazunori Saeki, Takayuki Yamada, Rena Uematsu, Miki Ishino, Nobuko Kito, Hiroki Nishikawa, Hidenobu Kuniyoshi, Takuya Matsumoto, Hideyasu Fujiwara, Linda J Paradiso, Yasuhiro Shimada and HIROYUKI IWAMURA
Journal of Pharmacology and Experimental Therapeutics April 13, 2018, jpet.118.248740; DOI: https://doi.org/10.1124/jpet.118.248740